ZA201604370B - Prostate cancer gene profiles and methods of using the same - Google Patents
Prostate cancer gene profiles and methods of using the sameInfo
- Publication number
- ZA201604370B ZA201604370B ZA2016/04370A ZA201604370A ZA201604370B ZA 201604370 B ZA201604370 B ZA 201604370B ZA 2016/04370 A ZA2016/04370 A ZA 2016/04370A ZA 201604370 A ZA201604370 A ZA 201604370A ZA 201604370 B ZA201604370 B ZA 201604370B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- same
- prostate cancer
- cancer gene
- gene profiles
- Prior art date
Links
- 108700019961 Neoplasm Genes Proteins 0.000 title 1
- 102000048850 Neoplasm Genes Human genes 0.000 title 1
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361921739P | 2013-12-30 | 2013-12-30 | |
| PCT/US2014/072610 WO2015103166A1 (en) | 2013-12-30 | 2014-12-29 | Prostate cancer gene profiles and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201604370B true ZA201604370B (en) | 2020-12-23 |
Family
ID=53493959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2016/04370A ZA201604370B (en) | 2013-12-30 | 2016-06-28 | Prostate cancer gene profiles and methods of using the same |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160326594A1 (enExample) |
| EP (1) | EP3090265B1 (enExample) |
| JP (1) | JP2017509351A (enExample) |
| CN (1) | CN106796236A (enExample) |
| AU (1) | AU2014373927B2 (enExample) |
| CA (1) | CA2934828A1 (enExample) |
| WO (1) | WO2015103166A1 (enExample) |
| ZA (1) | ZA201604370B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3519B1 (ar) | 2013-01-25 | 2020-07-05 | Amgen Inc | تركيبات أجسام مضادة لأجل cdh19 و cd3 |
| US11332794B2 (en) | 2016-01-19 | 2022-05-17 | Wayne State University | Prostate cancer aggressiveness gene signatures for subjects of African or European descent |
| AU2018266632B2 (en) * | 2017-05-12 | 2024-07-25 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine. Inc. | Prostate cancer gene profiles and methods of using the same |
| WO2019169336A1 (en) * | 2018-03-02 | 2019-09-06 | The Johns Hopkins University | Methods for prostate cancer detection |
| CN110054674B (zh) * | 2019-03-07 | 2022-08-05 | 深圳市龙华区人民医院 | 免疫原性多肽以及抗ttc36抗体ap2-19及应用 |
| CN110628908B (zh) * | 2019-09-19 | 2022-05-10 | 北京恩泽康泰生物科技有限公司 | 用于前列腺癌诊断分级和良恶性预测的生物标志物及检测试剂盒 |
| CN111893177B (zh) * | 2020-08-19 | 2022-10-04 | 南通大学 | 遗传性耳聋诱导基因的突变筛选方法及突变检测试剂盒 |
| CN113284559B (zh) * | 2021-07-21 | 2021-10-15 | 暨南大学 | 一种物种基因组的启动子查询方法、系统及设备 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US20050032065A1 (en) * | 2002-06-24 | 2005-02-10 | Afar Daniel E. H. | Methods of prognosis of prostate cancer |
| US20040191783A1 (en) * | 2003-03-31 | 2004-09-30 | Guy Leclercq | Low density micro-array analysis in human breast cancer |
| AU2005245815B2 (en) * | 2004-05-07 | 2011-06-09 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer |
| CA2588705A1 (en) * | 2004-11-24 | 2006-06-01 | St. George's Enterprises Limited | Diagnosis of prostate cancer |
| AU2006292212A1 (en) * | 2005-09-19 | 2007-03-29 | The Johns Hopkins University | Biomarker for prostate cancer |
| WO2008058018A2 (en) * | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| WO2008061104A2 (en) * | 2006-11-13 | 2008-05-22 | Invitrogen Corporation | Methods and kits for detecting prostate cancer biomarkers |
| CA2719172C (en) * | 2008-04-10 | 2020-08-25 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer-specific alterations in erg8 gene expression and detection and treatment methods based on those alterations |
| WO2013022995A2 (en) * | 2011-08-08 | 2013-02-14 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarker compositions and methods |
| WO2010065940A1 (en) * | 2008-12-04 | 2010-06-10 | The Regents Of The University Of California | Materials and methods for determining diagnosis and prognosis of prostate cancer |
| FR2945820A1 (fr) * | 2009-05-25 | 2010-11-26 | Univ Clermont Auvergne | Panel de genes pour le pronostic du cancer de la prostate |
| BR112012025593A2 (pt) * | 2010-04-06 | 2019-06-25 | Caris Life Sciences Luxembourg Holdings | biomarcadores em circulação para doença |
| WO2012015765A2 (en) * | 2010-07-27 | 2012-02-02 | Genomic Health, Inc. | Method for using gene expression to determine prognosis of prostate cancer |
| US20140148350A1 (en) * | 2010-08-18 | 2014-05-29 | David Spetzler | Circulating biomarkers for disease |
| WO2012031008A2 (en) * | 2010-08-31 | 2012-03-08 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| ES2593959T3 (es) * | 2011-04-19 | 2016-12-14 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Marcadores del cáncer de próstata |
| CA2835728A1 (en) * | 2011-05-12 | 2012-11-15 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| WO2013033609A2 (en) * | 2011-08-31 | 2013-03-07 | Oncocyte Corporation | Methods and compositions for the treatment and diagnosis of cancer |
| SE536352C2 (sv) * | 2011-10-24 | 2013-09-03 | Chundsell Medicals Ab | Markörgener för klassificiering av prostatacancer |
| CA2853745C (en) * | 2011-11-04 | 2019-12-31 | Noviogendix Research B.V. | Combinations of molecular markers in prostate cancer providing a diagnostic tool with improved sensitivity/specificity |
| US9863002B2 (en) * | 2012-06-04 | 2018-01-09 | North Carolina Central University | Genetic determinants of prostate cancer risk |
-
2014
- 2014-12-29 AU AU2014373927A patent/AU2014373927B2/en active Active
- 2014-12-29 JP JP2016561993A patent/JP2017509351A/ja active Pending
- 2014-12-29 WO PCT/US2014/072610 patent/WO2015103166A1/en not_active Ceased
- 2014-12-29 US US15/108,909 patent/US20160326594A1/en not_active Abandoned
- 2014-12-29 EP EP14877549.7A patent/EP3090265B1/en active Active
- 2014-12-29 CN CN201480076628.8A patent/CN106796236A/zh active Pending
- 2014-12-29 CA CA2934828A patent/CA2934828A1/en not_active Abandoned
-
2016
- 2016-06-28 ZA ZA2016/04370A patent/ZA201604370B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3090265A4 (en) | 2018-03-21 |
| US20160326594A1 (en) | 2016-11-10 |
| AU2014373927A1 (en) | 2016-07-07 |
| EP3090265A1 (en) | 2016-11-09 |
| CN106796236A (zh) | 2017-05-31 |
| JP2017509351A (ja) | 2017-04-06 |
| CA2934828A1 (en) | 2015-07-09 |
| AU2014373927B2 (en) | 2018-03-22 |
| WO2015103166A1 (en) | 2015-07-09 |
| EP3090265B1 (en) | 2020-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| EP3062808A4 (en) | Treatment of metastatic prostate cancer | |
| IL244510A0 (en) | Cancer biomarkers and their uses | |
| ZA201505735B (en) | Cancer drug and uses | |
| IL245297A0 (en) | Cancer models and related methods | |
| IL234581B (en) | Systems for heating with amplified microwaves and methods for using them | |
| GB201322725D0 (en) | Cancer therapy | |
| ZA201604370B (en) | Prostate cancer gene profiles and methods of using the same | |
| EP2967503A4 (en) | Systems and methods for treating prostate cancer | |
| SG11201508223YA (en) | Treatment of cancer with dihydropyrazino-pyrazines | |
| ZA201604369B (en) | Genomic rearrangements associated with prostate cancer and methods of using the same | |
| SG10201913730RA (en) | Cancer therapy | |
| ZA201507733B (en) | Treatment of cancer with dihydropyrazino-pyrazines | |
| EP2965086A4 (en) | Methods of detecting prostate cancer | |
| SG11201508878WA (en) | Methods of treating cancer | |
| SG11201507847UA (en) | Cancer therapy | |
| EP2970419B8 (en) | Methods of treating colorectal cancer | |
| EP3058067A4 (en) | Circulating cancer biomarker and its use | |
| ZA201507762B (en) | Methods of treating cancer | |
| EP2961412A4 (en) | CANCER THERAPY | |
| EP3024499A4 (en) | Model of colorectal cancer | |
| SG11201509367RA (en) | Methods for predicting and improving the survival of colorectal cancer patients | |
| GB201303115D0 (en) | Detection and treatment of liver cancer | |
| GB201317213D0 (en) | Cancer Therapy | |
| GB201202945D0 (en) | Novel cancer therapies and methods |